KKR has announced it has completed its acquisition of Envision Healthcare Corp.

The deal, which was previously announced in June, is valued at $9.9 billion.

Kohlberg Kravis Roberts (KKR) & Co., based in New York, considers investments in all industries, including healthcare. The firm is publicly traded under the ticker symbol KKR. It prefers to invest in a range of debt and public equity investing and may co-invest, seeking a controlling ownership of a company or a strategic minority position.

Envision, based in Nashville, Tenn., is a provider of physician-led services and post-acute care, and ambulatory surgery services. As of June 30, 2018, Envision says it delivered physician services s to more than 1,800 clinical departments in healthcare facilities in 45 states and the District of Columbia.

As a result of the acquisition, Envision became a wholly owned subsidiary of funds affiliated with KKR and Envision’s common stock ceased trading on the New York Stock Exchange.